4.0
Jul 21, 2025
Current employee, more than 3 years
Basel
Recommend
CEO approval
Business outlook
Pros
Encouragement of innovation and scientific exploration Decent budget for R&D initiatives Flexibility and autonomy in research activities Strong focus on cutting-edge biotech work
Cons
Departmental silos hinder cross-functional collaboration Communication across teams can be inconsistent Career development is promoted in principle, but lacks structured, company-wide programs Employee experience can differ significantly depending on department and manager